Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

2,161 results found

Article
Ask Lexy

DLA Piper | United Kingdom | 13 Dec 2021

Do medical devices have systematic bias?

An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare and…
Article
Ask Lexy

Hill Dickinson LLP | United Kingdom | 18 Oct 2021

Response from the government on the report into safety of maternity services in England

Earlier this year, the Health and Social Care Committee released its report on The Safety of Maternity Services in England. The report outlined…
Article
Ask Lexy

Bryan Cave Leighton Paisner LLP | European Union, United Kingdom | 5 Oct 2021

UK HR two minute monthly: October

Absence of appeal in unfair dismissal cases, the concept of "working time" under the Working Time Directive and part‑time workers. The Court of…
Article
Ask Lexy

Browne Jacobson LLP | United Kingdom | 14 Sep 2021

Updated guidance on Covid-19 vaccination: 12 to 15 year olds

On 13 September the Department of Health and Social Care announced that Young people aged 12 to 15 are to be offered a Covid-19 vaccine. People aged…
Analysis PRO In-house
Ask Lexy

Lexology PRO | Central & South America, European Union, France, etc. | 9 Aug 2021

CMA to probe “exploitative” coronavirus testing kit prices

The UK’s antitrust watchdog has agreed to advise the government on whether travellers are being charged excessive prices for covid-19 tests after the health secretary asked it to conduct a “rapid high-level review”.
Article
Ask Lexy

Kingsley Napley | United Kingdom | 30 Jul 2021

MPs call on Government to regulate non-surgical cosmetic treatments

There have long been calls for better oversight and regulation of the beauty industry. As an example, ahead of the General Dental Council (‘GDC’)…
Analysis PRO In-house
Ask Lexy

Lexology PRO | United Kingdom | 29 Jul 2021

CMA doles out £100 million in fines for excessive pricing of thyroid drug

The UK’s Competition and Markets Authority has hit Advanz Pharma and its two former owners with more than £100 million in fines for overcharging the country’s national health service for thyroid medication liothyronine over an eight-year period.
Article
Ask Lexy

Wilmer Cutler Pickering Hale and Dorr LLP | USA | 2 Apr 2021

New York Legalizes Marijuana—Where Is the US Headed?

It’s been an eventful week for the marijuana industry. After years of false starts, New York legalized The use of recreational marijuana on March…
Analysis PRO In-house
Ask Lexy

PRO Compliance | European Union, United Kingdom | 19 Jun 2020

UK makes belated switch to decentralised contact tracing

The UK government has switched to the decentralised model for its contact-tracing app – months after disregarding the ICO’s recommendation that it do so.
Article
Ask Lexy

Kingsley Napley | United Kingdom | 15 Apr 2020

Welcome relief for COVID-19 workers

The Chancellor, Rishi Sunak, has written to the chair of the Treasury Select Committee to confirm temporary changes to the Statutory Residence Test…
Previous page 1 2 3 ...